Maternal vaccine reduces influenza in infants

Article

The influenza vaccine in pregnant women can decrease risk of influenza in their infants up to 6 months of age and offer protection against febrile respiratory illness in both mothers and infants.

The use of influenza vaccine in pregnant women can decrease the risk of influenza in their infants up to 6 months of age and offer protection against febrile respiratory illness in both mothers and infants, according to research published online Sept. 17 in the New England Journal of Medicine.

Khalequz Zaman, PhD, of the International Centre for Diarrheal Disease Research in Dhaka, Bangladesh, and colleagues analyzed data from 340 Bangladeshi women in the third trimester of pregnancy, who were randomized to receive inactivated influenza vaccine or 23-valent pneumococcal polysaccharide vaccine. Mothers were interviewed weekly from birth until the infant was 24 weeks old to assess illnesses. The researchers focused on influenza or influenza-like illness in infants, and respiratory illness and fever in mothers and infants.

The researchers report that the influenza vaccine was associated with a 63% reduction in confirmed influenza illness in infants up to 6 months old, and a 29% and 36% decrease in rates of respiratory illness with fever in infants and mothers, respectively.

Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555-1564.

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.